News
Marvell Technology's 15% drop overlooks 69% data center growth, strong AI demand, and cheap valuation with high EPS potential. Read why MRVL stock is a strong buy.
Big Data Research, Precision Medicine and Real‑World Evidence in Autoimmune and Rheumatic Diseases
The unprecedented expansion of healthcare data—from electronic health records and insurance claims to biobank repositories and patient‑generated ...
Ischaemic heart disease (IHD) has historically been under-researched in women, leading to significant gaps in understanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback